Welcome to the Desert Angels™. We are a Tucson, Arizona based non-profit organization of accredited investors who seek opportunities to invest in Southwest regional startup or early stage companies. The organization serves as a forum for its over 100 members, who invest individually from their personal funds. Since 2000, Desert Angel members have invested over $29 million in more than 70 presenting companies.

Stimwave Receives FDA Clearance for World’s First Injectable Wireless MicroSize Pain Relief System for Chronic Back and Leg Pain

by gabrielsayegh on December 8th, 2014 at 5:28pm

Desert Angels portfolio company, Stimwave Technologies Incorporated; a medical device manufacturer and independent research institute headquartered in Miami Beach, Fla., has received FDA clearance to market the world’s first wireless, microtechnology neuromodulation device for relief of chronic back and leg pain. Currently being marketed throughout Europe, Stimwave announced it’s revolutionary electroceutical device will be commercially available in the U.S. as of January 2015.

Click here for the full article

Comment

NuvOx Pharma Awarded $1M Grant from National Cancer Institute

by gabrielsayegh on November 12th, 2014 at 5:57pm

Desert Angels portfolio company, NuvOx Pharma; a biotechnology company based in Tucson, Arizona, has received a $1M grant from the National Cancer Institute (NCI) “Nanoparticle-based Sensitizer for Radiation Therapy of Glioblastoma, (NCI Phase II SBIR, R44CA144817 – 02A1).” This grant comes less than a month after NuvOx was highlighted here for beginning Phase Ib clinical trial of its new drug — an oxygen-delivery agent — in patients with glioblastoma multiforme, a rare but particularly deadly form of brain cancer.

Click here for the full article

Comment

Filed under: Uncategorized

Picmonic receives $1.25 million in financing from local investors

by gabrielsayegh on November 12th, 2014 at 5:50pm

Desert Angels portfolio company, Picmonic; the Tempe-based company  which develops audiovisual study cards for medical students, has closed on $1.25 million in financing from local investors. Picmonic CEO and co-founder Ron Robertson said the money will help support the company’s move into the mobile industry and open up new markets in education. This financing, which closed in September, brings the company’s total money raised to $2.6 million.

Click here for the full article

Comment

Filed under: Funded Companies

Tucson Drug Startups in Key Clinical Trials

by gabrielsayegh on October 12th, 2014 at 10:53pm

Desert Angels portfolio companies, Cancer Prevention Pharmacuticals (CPP) & NuvOx Pharma (NuvOx), are in human clinical trials that could result in new drug approvals in the next few years. Both of these local startup companies are founded by University of Arizona research faculty. Local biosciences industry leaders say the companies’ progress in navigating the long and costly drug-approval process is noteworthy, as they progress through trials at the same time.

Click here for the full article

Comment

Filed under: Uncategorized

HTG Molecular Diagnostics Announces $16 Million Term Loan Agreement With Silicon Valley Bank and Oxford Finance

by gabrielsayegh on August 30th, 2014 at 8:41pm

Desert Angels portfolio company, HTG Molecular Diagnostics, announced that it has closed a growth capital term loan facility with Silicon Valley Bank and Oxford Finance. The loan facility provides HTG with up to $16 million of available proceeds, with $11 million funded at the initial closing this month.

For More: HTG Molecular Diagnostics Announces $16 Million Term Loan Agreement With Silicon Valley Bank and Oxford Finance

Comment

Gaming for good—with celebrities

by gabrielsayegh on August 30th, 2014 at 8:34pm

Fortune Magazine reported that Desert Angels portfolio company, Tiltify, capitalizes on livestreaming and opens up opportunities for celebrities, athletes and gamers to play for good causes.

For more: Gaming for good—with celebrities

Comment

Filed under: Funded Companies

Ranking Angel Investment Groups

by chrismarin on August 30th, 2014 at 8:30pm

Desert Angels is ranked among the top 20 angel investment groups of over 350 screened by CB Insights.

For more: Ranking Angel Investment Groups

Comment

Filed under: Press

Stem cell therapy could lead to HIV cure

by chrismarin on August 7th, 2014 at 4:03pm

Desert Angels portfolio company Calimmune is recognized for being at the forefont of developing a practical cure for people living with HIV infection.

Special note: The article erroneously credits the company as a San Diego based company – Calimmune is a Tucson based company.

For more: Stem cell therapy could lead to HIV cure

Comment

Filed under: Funded Companies, Press

NuvOx announces Phase Ib trial for Glioblastoma and additional NIH funding

by chrismarin on August 7th, 2014 at 3:42pm

NuvOx Pharma, a privately held biotechnology company based in Tucson, Arizona, announced that on July 14th, it began a Phase Ib clinical trial of its new drug NVX-108 in patients with glioblastoma, a deadly form of brain cancer.

For more: NuvOx announces Phase Ib trial for Glioblastoma and additional NIH funding

1 comment

Filed under: News Releases, Press

Contatta’s collaborative email now available for free public beta testing

by chrismarin on August 6th, 2014 at 12:17am

Contatta, the Scottsdale-based creator of the email application, announced Monday it is now free for anyone who wants to sign up online. It will become a paid service in the fall. Contatta is designed to address four common problems: collaboration and discussions with others, task management, contact management and keeping files handy.

For more: Contatta’s collaborative email now available for free public beta testing

Comment

Filed under: Funded Companies, Press